GlaxoSmithKline (GSK) Given a GBX 1,550 Price Target at UBS
UBS set a GBX 1,550 ($20.86) price target on GlaxoSmithKline (LON:GSK) in a research note issued to investors on Wednesday, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.
Other research analysts have also recently issued research reports about the stock. reaffirmed a buy rating and issued a GBX 1,970 ($26.51) price target on shares of GlaxoSmithKline in a report on Wednesday, September 13th. Liberum Capital reaffirmed a buy rating and issued a GBX 1,900 ($25.57) price target on shares of GlaxoSmithKline in a report on Wednesday, August 30th. Jefferies Group decreased their price target on shares of GlaxoSmithKline from GBX 1,900 ($25.57) to GBX 1,750 ($23.55) and set a buy rating for the company in a report on Thursday, August 24th. Berenberg Bank reaffirmed a buy rating and issued a GBX 1,835 ($24.70) price target on shares of GlaxoSmithKline in a report on Tuesday, September 19th. Finally, Goldman Sachs Group reaffirmed a buy rating and issued a GBX 1,900 ($25.57) price target on shares of GlaxoSmithKline in a report on Tuesday, October 17th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of GBX 1,562.86 ($21.03).
Shares of GlaxoSmithKline (GSK) opened at GBX 1,295 ($17.43) on Wednesday. GlaxoSmithKline has a 52-week low of GBX 1,270 ($17.09) and a 52-week high of GBX 1,724.50 ($23.21).
The company also recently declared a dividend, which will be paid on Thursday, January 11th. Investors of record on Thursday, November 9th will be given a dividend of GBX 19 ($0.26) per share. The ex-dividend date is Thursday, November 9th. This represents a yield of 1.41%.
In related news, insider Simon Dingemans bought 1,076 shares of the company’s stock in a transaction dated Thursday, October 12th. The shares were acquired at an average price of GBX 1,527 ($20.55) per share, for a total transaction of £16,430.52 ($22,113.76). Also, insider Urs Rohner bought 473 shares of the company’s stock in a transaction dated Wednesday, October 25th. The stock was bought at an average price of GBX 1,518 ($20.43) per share, for a total transaction of £7,180.14 ($9,663.71). In the last 90 days, insiders have purchased 1,577 shares of company stock worth $2,400,086.
GlaxoSmithKline Company Profile
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.